dc.contributor.author
Gregori, Josep
dc.contributor.author
Cortese, Maria Francesca
dc.contributor.author
Piñana, Maria
dc.contributor.author
Campos, Carolina
dc.contributor.author
Garcia-Cehic, Damir
dc.contributor.author
Andrés, Cristina
dc.contributor.author
Abril Ferrando, Josep Francesc, 1970-
dc.contributor.author
Codina, Maria Gema
dc.contributor.author
Rando, Ariadna
dc.contributor.author
Esperalba, Juliana
dc.contributor.author
Sulleiro, Elena
dc.contributor.author
Joseph, Joan
dc.contributor.author
Saubí, Narcís
dc.contributor.author
Colomer-Castell, Sergi
dc.contributor.author
Martin, Mari Carmen
dc.contributor.author
Castillo, Carla
dc.contributor.author
Esteban, Juan Ignacio
dc.contributor.author
Pumarola Suñé, Tomàs
dc.contributor.author
Rodríguez-Frías, Francisco
dc.contributor.author
Antón, Andrés
dc.contributor.author
Quer, Josep
dc.date.issued
2023-01-27T10:05:17Z
dc.date.issued
2023-01-27T10:05:17Z
dc.date.issued
2021-12-01
dc.date.issued
2023-01-27T10:05:17Z
dc.identifier
https://hdl.handle.net/2445/192657
dc.description.abstract
A common trait among RNA viruses is their high capability to acquire genetic variability due to viral and host mechanisms. Next-generation sequencing (NGS) analysis enables the deep study of the viral quasispecies in samples from infected individuals. In this study, the viral quasispecies complexity and single nucleotide polymorphisms of the SARS-CoV-2 spike gene of coronavirus disease 2019 (COVID-19) patients with mild or severe disease were investigated using next-generation sequencing (Illumina platform). SARS-CoV-2 spike variability was higher in patients with long-lasting infection. Most substitutions found were present at frequencies lower than 1%, and had an A → G or T → C pattern, consistent with variants caused by adenosine deaminase acting on RNA-1 (ADAR1). ADAR1 affected a small fraction of replicating genomes, but produced multiple, mainly non-synonymous mutations. ADAR1 editing during replication rather than the RNA-dependent RNA polymerase (nsp12) was the predominant mechanism generating SARS-CoV-2 genetic variability. However, the mutations produced are not fixed in the infected human population, suggesting that ADAR1 may have an antiviral role, whereas nsp12-induced mutations occurring in patients with high viremia and persistent infection are the main source of new SARS-CoV-2 variants.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Taylor and Francis
dc.relation
Reproducció del document publicat a: https://doi.org/10.1080/22221751.2021.1969868
dc.relation
Emerging Microbes & Infections, 2021, vol. 10, num. 1, p. 1777-1789
dc.relation
https://doi.org/10.1080/22221751.2021.1969868
dc.rights
cc-by (c) Gregori, Josep et al., 2021
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject
Mutació (Biologia)
dc.subject
Mutation (Biology)
dc.title
Host-dependent editing of SARS-CoV-2 in COVID-19 patients
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion